LINC00440: A Potential Drug Target and Biomarker (G100874172)

Target Name: LINC00440

NCBI ID: G100874172

LINC00440

Other Name(s): long intergenic non-protein coding RNA 440 | Long intergenic non-protein coding RNA 440

LINC00440: A Potential Drug Target and Biomarker

LINC00440 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of cancer. LINC00440 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancers.

The cell cycle is the process by which cells grow, divide, and replicate their genetic material. The cell cycle is regulated by a complex network of proteins that help ensure that each cell has the necessary amount of genetic material and that the cell divides properly. LINC00440 is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of cancer.

LINC00440 is a non-coding RNA molecule that is composed of 1,184 amino acid residues. It is expressed in various tissues and organs, including the brain, pancreas, and various types of cancer. LINC00440 has been shown to be highly expressed in breast, ovarian, and colorectal cancers, and it is also expressed in other types of cancer, such as lung and liver cancer.

One of the key functions of LINC00440 is that it regulates the cell cycle. It does this by binding to specific DNA sequences and preventing the binding of proteins that would disrupt the cell cycle. This helps ensure that cells have the necessary amount of genetic material and that the cell divides properly. LINC00440 also plays a role in the regulation of cell growth and the maintenance of tissue homeostasis.

In addition to its role in the cell cycle, LINC00440 has also been shown to be involved in the development and progression of cancer. For example, studies have shown that LINC00440 is highly expressed in various types of cancer and that it is associated with poor prognosis in cancer patients. Additionally, LINC00440 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. This is important for the development and maintenance of tissues and organs.

LINC00440 has also been shown to be involved in the regulation of cell survival. This is important for the regulation of cell growth and the maintenance of tissue homeostasis. LINC00440 has been shown to help ensure that cells have the necessary amount of genetic material and that the cell survives.

In conclusion, LINC00440 is a non-coding RNA molecule that is involved in the development, maintenance, and progression of cancer. It is highly expressed in various types of cancer and has been shown to play a role in the regulation of the cell cycle, cell growth, and cell survival. As a result, LINC00440 is a potential drug target and biomarker for cancer. Further research is needed to fully understand the role of LINC00440 in cancer and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 440

The "LINC00440 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00440 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets